DE60225307D1 - Verfahren zur herstellung von 17-allyl-amino-geldanamycin (17-aag) und anderer ansamycine - Google Patents

Verfahren zur herstellung von 17-allyl-amino-geldanamycin (17-aag) und anderer ansamycine

Info

Publication number
DE60225307D1
DE60225307D1 DE60225307T DE60225307T DE60225307D1 DE 60225307 D1 DE60225307 D1 DE 60225307D1 DE 60225307 T DE60225307 T DE 60225307T DE 60225307 T DE60225307 T DE 60225307T DE 60225307 D1 DE60225307 D1 DE 60225307D1
Authority
DE
Germany
Prior art keywords
aag
geldanamycin
allyl
ansamycines
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60225307T
Other languages
English (en)
Other versions
DE60225307T2 (de
Inventor
Lin Zhang
Marcus F Boehm
Siead Zegar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Conforma Therapeutics Corp
Original Assignee
Conforma Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conforma Therapeutics Corp filed Critical Conforma Therapeutics Corp
Publication of DE60225307D1 publication Critical patent/DE60225307D1/de
Application granted granted Critical
Publication of DE60225307T2 publication Critical patent/DE60225307T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60225307T 2001-09-24 2002-09-18 Verfahren zur herstellung von 17-allyl-amino-geldanamycin (17-aag) und anderer ansamycine Expired - Lifetime DE60225307T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32663901P 2001-09-24 2001-09-24
US326639P 2001-09-24
US33189301P 2001-11-21 2001-11-21
US331893P 2001-11-21
PCT/US2002/029715 WO2003026571A2 (en) 2001-09-24 2002-09-18 Process for preparing 17-allyl amino geldanamycin (17-aag) and other ansamycins

Publications (2)

Publication Number Publication Date
DE60225307D1 true DE60225307D1 (de) 2008-04-10
DE60225307T2 DE60225307T2 (de) 2009-03-19

Family

ID=26985493

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60225307T Expired - Lifetime DE60225307T2 (de) 2001-09-24 2002-09-18 Verfahren zur herstellung von 17-allyl-amino-geldanamycin (17-aag) und anderer ansamycine

Country Status (9)

Country Link
US (1) US7579462B2 (de)
EP (1) EP1435939B1 (de)
JP (1) JP2005504086A (de)
KR (1) KR20040054692A (de)
CN (1) CN100378079C (de)
AT (1) ATE387198T1 (de)
CA (1) CA2460498A1 (de)
DE (1) DE60225307T2 (de)
WO (1) WO2003026571A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
JP2005504086A (ja) 2001-09-24 2005-02-10 コンフォーマ セラピューティクス コーポレーション １７−アリルアミノゲルダナマイシン（１７−ａａｇ）および他のアンサマイシン類を製造する方法
EP2336133A1 (de) 2001-10-30 2011-06-22 Conforma Therapeutics Corporation Purinanaloga mit HSP90-inhibierender Wirkung
AU2003217393B8 (en) 2002-02-08 2009-06-25 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
BRPI0414533A (pt) 2003-09-18 2006-11-07 Conforma Therapeutics Corp composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90
AU2004309395C1 (en) 2003-12-23 2012-10-04 Infinity Discovery, Inc. Analogs of benzoquinone-containing ansamycins for the treatment of cancer
KR101045324B1 (ko) * 2004-08-11 2011-06-30 한국생명공학연구원 젤다나마이신 유도체 및 그 생합성 방법
US7371906B2 (en) 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
ES2663495T3 (es) * 2005-02-18 2018-04-13 Abraxis Bioscience, Llc Fármacos con hidrofobicidad mejorada para incorporación en dispositivos médicos
WO2006110473A2 (en) * 2005-04-07 2006-10-19 Conforma Therapeutics Corporation Phospholipid-based pharmaceutical formulations and methods for producing and using same
US7648976B2 (en) * 2005-11-23 2010-01-19 Bristol-Myers Squibb Company 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
US20090042847A1 (en) * 2005-11-23 2009-02-12 Kosan Biosciences Incorporated 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations
EP1954265A2 (de) * 2005-12-01 2008-08-13 Conforma Therapeutics Corporation Zusammensetzungen mit ansamycin
KR100796637B1 (ko) * 2006-09-29 2008-01-22 한국생명공학연구원 젤다나마이신 유도체, 이의 약학적으로 허용가능한 염,이의 제조방법 및 이를 유효성분으로 함유하는 암 예방 및치료제
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
PE20081506A1 (es) * 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
KR100861697B1 (ko) * 2007-01-30 2008-10-07 한국생명공학연구원 Ａｈｂａ 생합성 유전자 변이주를 이용한 안사마이신유도체의 생산 방법 및 신규한 안사마이신 유도체
JP5583680B2 (ja) 2008-10-15 2014-09-03 インフィニティー ファーマスーティカルズ インコーポレイテッド アンサマイシンヒドロキノン組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
BR9207024A (pt) 1992-01-06 1995-12-05 Pfizer Processo e utilizações para 4,5-DI-hidrogeldanamicina e sua hidroquinona
US5387584A (en) 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
CA2166320A1 (en) * 1993-06-29 1995-01-12 Randall James Gallaschun Ansamycin derivatives as antioncogene and anticancer agents
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US5883236A (en) * 1997-11-19 1999-03-16 Abbott Laboratories Process for N-desmethylating erythromycins and derivatives thereof
EP1169319A4 (de) 1999-04-09 2005-02-09 Sloan Kettering Institutefor C Methoden und zusammensetzungen zum abbau und /oder zur hemmung von tyrosin-kinasen der her-familie
JP2005504086A (ja) 2001-09-24 2005-02-10 コンフォーマ セラピューティクス コーポレーション １７−アリルアミノゲルダナマイシン（１７−ａａｇ）および他のアンサマイシン類を製造する方法
EP1923061A1 (de) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Verfahren zur Herstellung eines 17-Allyl-amino-Geldanamycins (17-AAG) und anderer Ansamycine

Also Published As

Publication number Publication date
KR20040054692A (ko) 2004-06-25
WO2003026571A2 (en) 2003-04-03
EP1435939A4 (de) 2004-12-29
US20050176695A1 (en) 2005-08-11
DE60225307T2 (de) 2009-03-19
CN100378079C (zh) 2008-04-02
EP1435939A2 (de) 2004-07-14
JP2005504086A (ja) 2005-02-10
US7579462B2 (en) 2009-08-25
WO2003026571A3 (en) 2003-10-02
ATE387198T1 (de) 2008-03-15
CA2460498A1 (en) 2003-04-03
EP1435939B1 (de) 2008-02-27
CN1558757A (zh) 2004-12-29

Similar Documents

Publication Publication Date Title
DE60225307D1 (de) Verfahren zur herstellung von 17-allyl-amino-geldanamycin (17-aag) und anderer ansamycine
DE60201480D1 (de) Verfahren zur Herstellung von hochreinem Xylylendiamin
DE50211242D1 (de) Vorrichtung und Verfahren zur Herstellung von im Wesentlichen halogenfreien Trialkoxysilanen
DE50208864D1 (de) Verfahren zur herstellung von arylaminen
NO20053473L (no) Fremgangsmate for fremstilling av R,R (eller S,S) konfigurasjonen av glykopyrroniumstereoisomerer
DE60234952D1 (de) VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
DE60206996D1 (de) Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
DE60225433D1 (de) Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen
DE60217096D1 (de) Verfahren zur herstellung von (s)-(+)- und (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepin-5-carboxamid
DE602004025267D1 (de) Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
DE60227517D1 (de) Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
DE60239286D1 (de) Verfahren zur herstellung von trans-1,4-cyclohexandicarbonsäure
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE60220554D1 (de) Mikrowelleninduzierter prozess zur herstellung von substituierten 4-vinylphenolen
DE60300144D1 (de) Verfahren zur Herstellung von Al-Sinterlegierung
DE60239085D1 (de) Prozess zur Herstellung von E-Caprolactam
DE60214469D1 (de) Verfahren zur Herstellung von Zirkoniapulver
DE60003807D1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE60108105D1 (de) Verfahren zur Herstellung von 5-substituierten Isobenzofuranen
EP1436279A4 (de) Chemische verbindungen
DE60230097D1 (de) Verfahren zur herstellung von 1,5-diaminonaphthalinen
DE60208551D1 (de) Verfahren zur herstellung von racemischen und enantiomerenreinen derivaten von 1,5-diaryl-3-trifluormethyl-delta2-pyrazolinen
DE502004011536D1 (de) verfahren zur herstellung von bengamide-derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition